At the XXIII International Congress of the Brazilian Society of Ophthalmology in June, we introduced our medical education program “Advancing Ophthalmology,” designed to support local #EyeCare professionals in raising the standard of care in their clinics. Explore our research interests and areas of focus in this field: https://bit.ly/3Sh2UBp
About us
AbbVie is a global biopharmaceutical company focused on creating medicines and solutions that put impact first — for patients, communities, and our world. We aim to address complex health issues and enhance people's lives through our core therapeutic areas: immunology, oncology, neuroscience, eye care, aesthetics and other areas of unmet need. Learn more about us at www.abbvie.com and review our community guidelines at https://www.abbvie.com/social-media-community-guidelines.html.
- Website
-
http://www.abbvie.com
External link for AbbVie
- Industry
- Pharmaceutical Manufacturing
- Company size
- 10,001+ employees
- Headquarters
- North Chicago, Illinois
- Type
- Public Company
- Specialties
- Biopharmaceutical, Biotechnology, Innovation, Research and Development, Manufacturing, Biotherapeutics, Oncology, Immunology, Virology, Neuroscience, Womens Health, Aesthetics, and Eye Care
Locations
Employees at AbbVie
Updates
-
Thank you, Disability:IN and the American Association of People with Disabilities, for honoring us with a top score on the Disability Equality Index and recognition as a Best Place to Work for Disability Inclusion. Learn more: https://bit.ly/3zM2Web #BelongAtAbbVie #BestPlaceToWork24 #AreYouIN
-
Meet the experts leading one of the largest #data initiatives in the biopharma industry. See how this platform enables #ArtificialIntelligence tools to transform the future of medicine: https://bit.ly/3Y6b1oj #DataScience #AIAppreciationDay [Video description: Four AbbVie employees discuss the importance of data and meaning of data convergence].
-
Join us in congratulating our team of #scientists who received the American Chemical Society's 2024 #HeroesOfChemistry Award for their discovery and development of a medicine for #autoimmune diseases. This award is the highest honor for industrial chemical scientists.
-
Seramount has named us to their list of 100 Best Companies. This honor reflects our inclusive work environment that supports families, working parents and caregivers. Learn more: https://bit.ly/3W7KBzD #BelongAtAbbVie #Seramount100Best
-
Sometimes, breaking through scientific barriers requires inventing something new. With over 600 novel instruments under their belt, that’s just what our SPaRCS team has done. Hear two scientists on the team, Andrew Radosevich and David A. Chang-Yen, share how SPaRCS is developing technologies that enable life-changing therapies. This is how we’re building the lab of the future: https://bit.ly/4cyMNaz [Video description: AbbVie scientists Andrew Radosevich and David Chang-Yen share an overview of the SPaRCS team. On-screen text reads, “People. Passion. Possibilities.”]
-
In June, we partnered with the International Agency for the Prevention of Blindness (IAPB) to lead a session on diabetic eye conditions at 2030 IN SIGHT LIVE in Mexico City. The session brought together global experts for a critical conversation on the importance of a multisectoral approach to improve care for people living with diabetic retinopathy and diabetic macular edema. Explore our research areas and efforts in #EyeCare: https://bit.ly/4fcBI0L #2030InSight
-
Today, we announced that Roopal Thakkar has been appointed Chief Scientific Officer for AbbVie. Roopal will lead our R&D organization of more than 14,000 team members as we discover and develop future breakthrough medicines for patients. Read more about the news: https://bit.ly/3XWFh4D
-
#ParkinsonsDisease (PD) doesn’t sleep. But by studying the data on its impact on sleep, we can better support patients and help them be more aware of their symptoms. Explore the results from a recent patient survey developed by PD Avengers: https://bit.ly/3xOkrKh [Video description: On-screen text outlines the five most common symptoms PD patients report experiencing during sleep, including frequent awakenings; insomnia; bradykinesia; rigidity; and nocturia. On-screen text, “We are proud to sponsor the PD Avengers SLEEP survey.”]
-
Reminder: Applications for the Golden Ticket competition from University Lab Partners, supported by Allergan Aesthetics, close on July 8. Aesthetic #startups are invited to apply – see more details below. ⬇
Advancing the frontier of medical aesthetics depends on investing in the bright minds of tomorrow. That’s why we’re proud to support the 2nd annual Golden Ticket competition with University Lab Partners. Open to aesthetic startup leaders, we invite you to take advantage of this opportunity to win a lab bench for one year with state-of-the-art scientific facilities and equipment, proper environmental health and safety disposal measures, access to UCI core facilities, and complimentary memberships to prominent life science trade associations. Applications are open until July 8, apply today! https://lnkd.in/gt5gM8gN
Affiliated pages
Similar pages
Browse jobs
Stock
ABBV
NYSE
20 minutes delay
$175.27
6.07 (3.588%)
- Open
- 169.51
- Low
- 169.51
- High
- 175.74
Data from Refinitiv
See more info on